https://www.fda.gov/news-events/press-announcements/fda-raises-concerns-about-probiotic-products-sold-use-hospitalized-preterm-infants
The agency is advising the public, including healthcare providers, of the possible risks that probiotic products pose to preterm infants in hospital settings.
Create an account
or login to join the discussion